Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong

Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong

Human papillomavirus (HPV) can cause several diseases, including cancers, in both sexes. In January 2020, the Hong Kong government launched a school-based vaccination program for girls 10–12 years of age with the 9-valent HPV (9vHPV) vaccine for the prevention of HPV-related diseases; however, boys...

Full description

Bibliographic Details
Main Authors: Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu, Queenie Wing-Lei Wong, Andrew Pavelyev, Isaya Sukarom, Kunal Saxena
Format: Article
Language:English
Published: Taylor & Francis Group 2023-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
human papillomavirus
vaccine
head and neck cancer
cost-effectiveness
hong kong
Online Access:http://dx.doi.org/10.1080/21645515.2023.2184605

Similar Items

Similar Items